Group 1 - The core point of the article is that Chengda Pharmaceutical (301201) announced a plan for a significant share reduction by its shareholder Qianhai Shengtai Investment Enterprise (Limited Partnership) [1] - Qianhai Shengtai holds 11,006,900 shares, accounting for 7.27% of the company's total share capital after excluding repurchased shares [1] - The shareholder plans to reduce its holdings by up to 11,006,970 shares within three months after the announcement date, using centralized bidding or block trading methods [1]

Group 1 - The core point of the article is that Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership), a shareholder holding 11,006,900 shares (7.27% of the total share capital after excluding repurchased shares) of Chengda Pharmaceutical (301201.SZ), plans to reduce its holdings within a specified timeframe [1] Group 2 - The planned reduction of shares will occur through centralized bidding or block trading methods [1] - The reduction period is set from September 29, 2025, to December 28, 2025 [1] - The maximum number of shares to be reduced is also 11,006,900, maintaining the same percentage of 7.27% of the total share capital after excluding repurchased shares [1]

Group 1 - The core point of the article is that Chengda Pharmaceutical (301201) announced that its shareholder Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership) plans to reduce its stake by up to 11,006,900 shares, which represents 7.11% of the company's total share capital, within three months after 15 trading days [1] Group 2 - The reduction will be executed through centralized bidding or block trading methods [1] - The announcement was made on the evening of September 5 [1] - The shareholder currently holds a 7.11% stake in the company [1]

Core Viewpoint - Chengda Pharmaceutical (301201) announced that its shareholder Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership) plans to reduce its holdings of 11.0069 million shares, representing 7.27% of the company's total share capital after excluding repurchased shares, within three months from September 29, 2025, to December 28, 2025, through centralized bidding or block trading [1] Summary by Relevant Sections - Shareholder Reduction Plan - Shenzhen Qianhai Shengtai Investment Enterprise intends to reduce its stake by up to 11.0069 million shares [1] - This reduction accounts for 7.27% of the company's total share capital after excluding repurchased shares [1] - The planned reduction period is from September 29, 2025, to December 28, 2025 [1] - Trading Method - The shares will be sold through centralized bidding or block trading methods [1]